SCHEMBL17946118

SCHEMBL17946118

O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccc(Cl)cc2)CC1

nearest known ligand 0.88

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADIPOR2 Q86V24 1/20 0.88
ADIPOR1 Q96A54 1/20 0.88
POLB P06746 1/20 0.72
USP2 O75604 1/20 0.70
LMNA P02545 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
ALDH1A1 P00352 2/20 0.64
SIGMAR1 Q99720 1/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
ATF4 P18848 3/20 0.63
MAPK1 P28482 1/20 0.63
MCHR1 Q99705 4/20 0.62
FAAH O00519 1/20 0.62
BCHE P06276 1/20 0.62
ACHE P22303 1/20 0.62
DRD4 P21917 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17950883 0.97 ADIPOR2 (0.90) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL17938602 0.94 ADIPOR2 (1.00) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL24514196 0.91 ADIPOR2 (0.73) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL25568933 0.91 ADIPOR2 (0.73) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL24514572 0.90 ADIPOR2 (0.81) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL24514569 0.89 ADIPOR2 (0.70) ADIPOR2ADIPOR1POLBUSP2SIGMAR1
SCHEMBL25568932 0.88 ADIPOR2 (0.77) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL25568934 0.87 ADIPOR2 (0.67) ADIPOR2ADIPOR1POLBUSP2ATF4
SCHEMBL21064273 0.84 ADIPOR2 (0.78) ADIPOR2ADIPOR1POLBUSP2LMNA
SCHEMBL24514564 0.84 ADIPOR2 (0.82) ADIPOR2ADIPOR1POLBUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170298051-A1 ACTIVATOR OF ADIPONECTIN RECEPTOR THE UNIVERSITY OF TOKYO (JP) 2017-10-19 US disclosed
US-20170298051-A1 ACTIVATOR OF ADIPONECTIN RECEPTOR THE UNIVERSITY OF TOKYO (JP) 2017-10-19 US disclosed
EP-3053911-A1 ADIPONECTIN RECEPTOR-ACTIVATING COMPOUND The University of Tokyo (JP) 2016-08-10 EP disclosed
US-20160214967-A1 ACTIVATOR OF ADIPONECTIN RECEPTOR THE UNIVERSITY OF TOKYO (JP) 2016-07-28 US disclosed
US-20160214967-A1 ACTIVATOR OF ADIPONECTIN RECEPTOR THE UNIVERSITY OF TOKYO (JP) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214967-A1 ACTIVATOR OF ADIPONECTIN RECEPTOR ADIPOR1, ADIPOR2, CCKAR ADIPOR2 2/4885ADIPOR1 1/4885POLB 4574/4885
US-20170298051-A1 ACTIVATOR OF ADIPONECTIN RECEPTOR ADIPOR1, ADIPOR2, CCKAR ADIPOR2 2/4885ADIPOR1 1/4885POLB 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.